Nymox

NYMX NASDAQ
1.745
-0.015
-0.85%
Opening 14:10 08/22 EDT
Open
1.760
Prev Close
1.760
High
1.760
Low
1.660
Volume
24.72K
Avg Vol (3M)
146.71K
52 Week High
2.930
52 Week Low
1.250
% Turnover
0.04%
Market Cap
118.53M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Nymox NYMX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the aging population segment. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also owns rights for its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The Company's subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex, Inc. conducts research and development, and manufacturing of NicAlert and TobacAlert.
MORE >

Recently

Name
Price
%Change